JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M202060200 on July 1, 2002

J. Biol. Chem., Vol. 277, Issue 40, 37242-37253, October 4, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/40/37242    most recent
M202060200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, M. K.
Right arrow Articles by Uhler, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, M. K.
Right arrow Articles by Uhler, M. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Autoinhibition and Isoform-specific Dominant Negative Inhibition of the Type II cGMP-dependent Protein Kinase*

Merritt K. TaylorDagger §, Rehan Ahmed, Michael Begley||, and Michael D. Uhler||**

From the Dagger  Neuroscience Graduate Program, the  School of Public Health, the || Department of Biological Chemistry, and the ** Mental Health Research Institute, University of Michigan, Ann Arbor, Michigan 48104

In the absence of cyclic nucleotides, the cAMP-dependent protein kinase and cGMP-dependent protein kinases (cGKs) suppress phosphotransfer activity at the catalytic cleft by competitive inhibition of substrate binding with a pseudosubstrate sequence within the holoenzyme. The magnitude of inhibition can be diminished by autophosphorylation near this pseudosubstrate sequence. Activation of type I cGK (cGKI) and type II cGK (cGKII) are differentially regulated by their cyclic nucleotide-binding sites. To address the possibility that the distinct activation mechanisms of cGKII and cGKI result from differences in the autophosphorylation of the inhibitory domain, we investigated the effects of autophosphorylation on the kinetics of activation. Unlike the type I cGKs (cGKIalpha and Ibeta ), cGKII autophosphorylation did not alter the basal activity, nor the sensitivity of the enzyme to cyclic nucleotide activation. To determine residues responsible for autoinhibition of cGKII, Ala was substituted for basic residues (Lys122, Arg118, and Arg119) or a hydrophobic residue (Val125) within the putative pseudosubstrate domain of cGKII. The integrity of these residues was essential for full cGKII autoinhibition. Furthermore, a cGKII truncation mutant containing this autoinhibitory region demonstrated a nanomolar IC50 toward a constitutively active form of cGKII. Finally, we present evidence that the dominant negative properties of this truncation mutant are specific to cGKII when compared with cAMP-dependent protein kinase Calpha and cGKIbeta . These findings extend the known differences in the activation mechanisms among cGK isoforms and allow the design of an isoform-specific cGKII inhibitor.


* This work was supported by National Institutes of Heath Grant GM50791 and the Michigan Diabetes Research and Training Center.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Current address: 3215 CCGC, University of Michigan, Ann Arbor, MI 48109-0934.

Dagger To whom correspondence should be addressed: C560 MSRB II, 1150 West Medical Center, University of Michigan, Ann Arbor, MI 48109-0669. Tel.: 734-647-3172; Fax: 734-936-2690; E-mail: muhler@umich.edu.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. B. Vaandrager, B. M. Hogema, M. Edixhoven, C. M. M. van den Burg, A. G. M. Bot, P. Klatt, P. Ruth, F. Hofmann, J. Van Damme, J. Vandekerckhove, et al.
Autophosphorylation of cGMP-dependent Protein Kinase Type II
J. Biol. Chem., August 1, 2003; 278(31): 28651 - 28658.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Hou, J. Lascola, N. O. Dulin, R. D. Ye, and D. D. Browning
Activation of cGMP-dependent Protein Kinase by Protein Kinase C
J. Biol. Chem., May 2, 2003; 278(19): 16706 - 16712.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.